Aligos Therapeutics (ALGS) Other Gross PP&E Adjustments (2021 - 2025)
Historic Other Gross PP&E Adjustments for Aligos Therapeutics (ALGS) over the last 5 years, with Q3 2025 value amounting to $10.9 million.
- Aligos Therapeutics' Other Gross PP&E Adjustments rose 2507.45% to $10.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.9 million, marking a year-over-year increase of 2507.45%. This contributed to the annual value of $7.6 million for FY2024, which is 6083.1% up from last year.
- According to the latest figures from Q3 2025, Aligos Therapeutics' Other Gross PP&E Adjustments is $10.9 million, which was up 2507.45% from $10.2 million recorded in Q2 2025.
- In the past 5 years, Aligos Therapeutics' Other Gross PP&E Adjustments ranged from a high of $10.9 million in Q3 2025 and a low of $3.4 million during Q4 2021
- In the last 5 years, Aligos Therapeutics' Other Gross PP&E Adjustments had a median value of $7.1 million in 2023 and averaged $7.0 million.
- In the last 5 years, Aligos Therapeutics' Other Gross PP&E Adjustments plummeted by 729.84% in 2022 and then skyrocketed by 6083.1% in 2024.
- Over the past 5 years, Aligos Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at $3.4 million in 2021, then soared by 34.74% to $4.6 million in 2022, then rose by 2.38% to $4.7 million in 2023, then skyrocketed by 60.83% to $7.6 million in 2024, then skyrocketed by 43.07% to $10.9 million in 2025.
- Its last three reported values are $10.9 million in Q3 2025, $10.2 million for Q2 2025, and $9.5 million during Q1 2025.